This detection rate could point to a more selective search strategy, guided by the presence of clinical features that might suggest a higher likelihood of AATD such as younger age and greater severity of COPD, which in our analysis were identified as factors associated with the determination of AAT levels. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.